# MF TRUST-7 — stabilization and real-use proof

**Status:** complete; seven-day use accepted, exit review waived by owner  
**Owner:** MoneyFlow  
**Issue/PR:** #123 / #132  
**Owner-use evidence:** #127  
**Last updated:** 2026-07-29

## Outcome

MoneyFlow completed the TRUST-7 technical stabilization phases and the owner explicitly confirmed seven days of real use. On 2026-07-29 the owner chose to skip the remaining exit-review phase and proceed to a separate evidence-driven defect plan.

The skipped checks are recorded as **waived**, not passed. No CSV result, missing/duplicate review, median entry time or replacement-method count is invented.

## Repository reconnaissance

### Delivered phases

- Phase 0 shipped through PR #124: repository and tracking reconciliation.
- Phase 1 shipped through PR #125: Dashboard keep-open and deterministic balance fixes.
- Phase 2 shipped through PR #126: R0–R6 readiness synchronization, Supabase #40 constraint and authenticated mutation-RPC audit.
- Phase 3 seven-day owner-use duration was accepted through PR #131 and #127.
- The owner reported multiple defects from real use and reserved remediation for a separate plan.

### Repository authorities

| Area | Authority |
|---|---|
| R0–R7 readiness claims | `docs/REAL_USE_READINESS_CONTRACT.md` |
| TRUST-7 final execution state | `docs/plans/active/mf-trust-7.md` |
| Master external tracker | GitHub #123 |
| Seven-day owner-use evidence | GitHub #127 |
| Supabase leaked-password constraint | GitHub #40 |
| Deferred UI/brand work | GitHub #72 and PR #119 |

### Technical constraints retained

- VND remains integer đồng with safe-integer validation.
- Income, expense and transfer remain distinct.
- Transfers remain net-zero and excluded from income/expense/category/budget totals.
- Financial writes retain idempotency and tenant isolation.
- Export retains formula-injection protection and UTF-8/Vietnamese handling.
- Static, build, database and browser gates remain required for implementation PRs.
- Evidence must exclude credentials, tokens, private email addresses and real financial descriptions.

## Research

### Owner decision

The owner explicitly chose to skip the remaining TRUST-7 exit-review work. This decision changes project sequencing but does not retroactively prove the skipped checks.

Waived evidence:

- final self-use CSV export/open check;
- sanitized missing/duplicate comparison;
- median entry time from at least five measurements;
- count of days MoneyFlow replaced the previous method.

The owner had already reported multiple real-use defects and stated that they would be handled under another plan. Therefore the recorded exit direction is **proceed to a separate blocker/defect plan**, not unrestricted feature expansion.

## Specification

### Final TRUST-7 finding

- [x] MoneyFlow was used in real life for seven days.
- [x] Real use revealed multiple defects.
- [x] Defect remediation is deferred to a separate plan.
- [x] The remaining exit-review checks were explicitly waived by the owner.
- [x] Waived checks are not represented as passed or verified.
- [x] Phase 4 defect planning is unblocked.

### Waived items

- [~] Final CSV exported and opened in a normal spreadsheet application — waived, not verified.
- [~] Sanitized sample checked for missing or duplicate rows — waived, not verified.
- [~] Median entry time recorded from at least five measurements — waived, not measured.
- [~] Number of days MoneyFlow replaced the previous method — waived, not measured.

### Scope boundary after TRUST-7

- A separate defect plan may now be opened.
- Real-use defects must be captured with synthetic or sanitized descriptions.
- Severity must be based on user impact and reproducible behavior.
- P0/P1 correctness and blocking friction come before redesign or feature breadth.
- #40 remains plan-blocked until the managed Supabase setting is actually available and enabled.
- #72 and PR #119 are not automatically authorized by closing TRUST-7.

## Implementation plan

### Phase 4 entry rule

The next plan must begin with:

1. sanitized defect inventory from the seven-day use period;
2. severity classification based on actual impact;
3. reproducible steps and affected routes/states;
4. observable acceptance criteria;
5. one bounded PR per coherent defect group;
6. production verification for every P0/P1 fix.

### Tasks

| ID | Task | Evidence | Status |
|---|---|---|---|
| P0 | Freeze and repository reconciliation | PR #124 | done |
| P1 | Core correctness fixes | PR #125 | done |
| P2 | Security/manual readiness synchronization | PR #126 | done |
| P3-1 | Confirm seven days of real owner use | owner confirmation / #127 / PR #131 | done |
| P3-2 | Final CSV and missing/duplicate review | owner decision | waived, not verified |
| P3-3 | Entry-time and replacement-method summary | owner decision | waived, not measured |
| P3-4 | Record exit direction | owner instruction on 2026-07-29 / PR #132 | done — proceed to defect plan |
| P4 | Open separate evidence-driven defect plan | after TRUST-7 closure | ready |

## Evaluation

| Criterion | Evidence | Result |
|---|---|---|
| Phase 0 delivered | PR #124 | pass |
| Phase 1 delivered | PR #125 | pass |
| Phase 2 delivered | PR #126 | pass |
| Seven days of real use occurred | explicit owner confirmation / #127 / PR #131 | pass |
| Multiple real-use defects observed | explicit owner confirmation | pass; details deferred |
| Final CSV opened | owner waived | not verified |
| Missing/duplicate review | owner waived | not verified |
| Median entry time | owner waived | not measured |
| Previous-method replacement count | owner waived | not measured |
| Exit direction | owner instruction / PR #132 | proceed to separate defect plan |

### Remaining limitations

- Exact daily calendar dates were not supplied and are not invented.
- The defect set has not yet been captured or classified.
- Skipped exit evidence cannot be cited later as if it passed.
- #40 remains plan-blocked on the current Supabase Free plan.
- Closing TRUST-7 does not itself validate redesign, logo or feature work.

## Delivery record

- Phase 0 branch/PR: `agent/mf-trust-7-phase-0` / #124
- Phase 0 squash commit: `93a8ac52aa94b7a8451e27be86af8567806b450c`
- Phase 1 branch/PR: `agent/mf-trust-7-phase-1` / #125
- Phase 1 squash commit: `470f4ac6a79dd925eef6a834d745b768c7650967`
- Phase 1 CI: #501 — verify, database and e2e passed
- Phase 1 production deployment: `dpl_14kdUsxkxruYnBVYThQWUu9msJzh` — READY
- Phase 2 branch/PR: `agent/mf-trust-7-phase-2` / #126
- Phase 2 squash commit: `2f0150ff68078919a0e22d7d915f47b9a777c8e3`
- Phase 2 CI: #504 — verify, database and e2e passed
- Phase 3 documentation branch/PR: `agent/mf-trust-7-phase-3-start` / #131
- Phase 3 owner-use evidence: #127
- Exit-review waiver branch/PR: `agent/mf-trust-7-waive-exit-review` / #132
- Exit-review waiver: owner instruction on 2026-07-29
- Production behavior change: none
- Next authorized work: separate evidence-driven defect plan